Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Warner Chilcott Plc > Profile

Warner Chilcott Plc (WCRX)

Market is closed

Related Insiders

Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
Murray
 $21.42 4,226,145 $90,505,853.48 33,819,259 2009-11-25 Filing
Jp
 $21.42 248,314 $5,317,818.13 1,987,108 2009-11-25 Filing
Jp
 $21.42 65,022 $1,392,491.65 520,333 2009-11-25 Filing
Jp
 $21.42 286,812 $6,142,279.75 2,295,177 2009-11-25 Filing
Jp
 $21.42 32,074 $686,887.16 256,673 2009-11-25 Filing
News See All
Joel Greenblatt's Top Picks Include United Therapeutics and Activision Blizzard

Joel Greenblatt's Top Picks Include United Therapeutics and Activision Blizzard

One of the funds we track is Joel Greenblatt's Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at the end of the third quarter of the year.

Keep Reading →

November 15th, 2013 - Hedge Funds News

Hedge Funds Are Dumping Dr. Reddy's Laboratories Limited (ADR) (RDY)

Hedge Funds Are Dumping Dr. Reddy's Laboratories Limited (ADR) (RDY)

To many of your fellow Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY) investors, hedge funds are perceived as overrated, outdated investment vehicles of an era lost to time.

Keep Reading →

September 11th, 2013 - News

Eli Lilly & Co. (LLY), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Where We're Headed

Eli Lilly & Co. (LLY), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Where We're Headed

Over the past couple of months we've discussed many of the biggest risk factors associated with some of the leading causes of death in the United States -- heart disease, cancer and stroke.

Keep Reading →

September 3rd, 2013 - News

Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)

Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)

If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.

Keep Reading →

August 29th, 2013 - News

What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)

What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)

In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge fund and insider trading sentiment.

Keep Reading →

August 28th, 2013 - News

Hedge Funds Are Crazy About Endo Health Solutions Inc (ENDP)

Hedge Funds Are Crazy About Endo Health Solutions Inc (ENDP)

To many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.

Keep Reading →

August 27th, 2013 - News

Hedge Funds Are Betting On Warner Chilcott Plc (WCRX)

Hedge Funds Are Betting On Warner Chilcott Plc (WCRX)

In today’s marketplace, there are tons of indicators investors can use to track the equity markets. A couple of the most underrated are hedge fund and insider trading sentiment.

Keep Reading →

August 27th, 2013 - News

Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.

Keep Reading →

August 26th, 2013 - News

Forest Laboratories, Inc. (FRX): Hedge Funds Aren't Crazy About It, Insider Sentiment Unchanged

Forest Laboratories, Inc. (FRX): Hedge Funds Aren't Crazy About It, Insider Sentiment Unchanged

If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost to time.

Keep Reading →

August 25th, 2013 - News

Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren't Crazy About It

Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren't Crazy About It

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds' portfolio at the end of March. TARO investors should pay attention to an increase in enthusiasm from smart money in recent months.

Keep Reading →

July 1st, 2013 - News

Click here to See All News
Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)